| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6372dde89a8ac6af866c273e9f3f8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20 |
| filingDate |
2021-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf300dcf80652b1d4194809f95a12aff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f4d988fb2c791b3f021e50f71d0385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e76a0bca1defac51623392b0bad1747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a66582eb123a69709657d78de08558 |
| publicationDate |
2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102344631-B1 |
| titleOfInvention |
Method and device for measuring the risk of dyslipidemia associated with cold genetics |
| abstract |
Disclosed are a method and apparatus for measuring the risk of genetic-associated dyslipidemia in cold. According to an embodiment of the present invention, a method for measuring the risk of genetically associated dyslipidemia with poor circulation comprises the steps of first classifying a plurality of participants to be analyzed into a cold-blooded group and a non-cold-sensitive group based on a survey conducted; Secondary classification of some of the participants satisfying the selected condition among the plurality of participants into a dyslipidemia group based on clinical information; designing a causal relationship between the genetic factor of poor circulation with respect to the first divided dyslipidemia group and the dyslipidemia genome for the second divided dyslipidemia group; And in consideration of the causal relationship, it includes the step of measuring the risk of dyslipidemia for the participant belonging to the cold syndrome. |
| priorityDate |
2021-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |